Profits of pharmaceutical companies in poor countires, BBC Radio 4, 28 September 2005

Professor Stefan Szymanski, co-author of Parallel Trade, price discrimination, investment and price caps with Dr Tommaso Valletti, discusses the profits of pharmaceutical companies in rich countries.

PHARMACEUTICAL INDUSTRY

Is it necessary to protect the profits of pharmaceutical companies in rich countries if drugs are to be supplied on humanitarian grounds to poor countries?

Laurie Taylor is joined by Stefan Szymanski, Professor at Tanaka Business School , Imperial College London, and author of Parallel Trade, price discrimination, investment and price caps and Dr Mary Moran, director of the Pharmaceutical R&D Policy Project at the London School of Economics to discuss the implications of this.